These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 17049460)

  • 1. GnRH agonists vs antagonists.
    Tarlatzis BC; Kolibianakis EM
    Best Pract Res Clin Obstet Gynaecol; 2007 Feb; 21(1):57-65. PubMed ID: 17049460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are GnRH antagonists comparable to agonists for use in IVF?
    Huirne JA; Homburg R; Lambalk CB
    Hum Reprod; 2007 Nov; 22(11):2805-13. PubMed ID: 17872909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GnRH antagonists.
    Coccia ME; Comparetto C; Bracco GL; Scarselli G
    Eur J Obstet Gynecol Reprod Biol; 2004 Jul; 115 Suppl 1():S44-56. PubMed ID: 15196716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Biological assessment criteria during antagonist protocols].
    Plachot M
    J Gynecol Obstet Biol Reprod (Paris); 2004 Oct; 33(6 Pt 2):3S32-5. PubMed ID: 15643685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GnRH antagonist in in vitro fertilization: where we are now.
    Shapiro DB; Mitchell-Leef D
    Minerva Ginecol; 2003 Oct; 55(5):373-88. PubMed ID: 14581880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GnRH agonists, antagonists, and assisted conception.
    van Loenen AC; Huirne JA; Schats R; Hompes PG; Lambalk CB
    Semin Reprod Med; 2002 Nov; 20(4):349-64. PubMed ID: 12536358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does day 3 luteinizing-hormone level predict IVF success in patients undergoing controlled ovarian stimulation with GnRH analogues?
    Orvieto R; Meltzer S; Rabinson J; Gemer O; Anteby EY; Nahum R
    Fertil Steril; 2008 Oct; 90(4):1297-300. PubMed ID: 18249369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Optimizing ovarian stimulation for IVF using GnRH antagonists].
    Kolibianakis EM
    J Gynecol Obstet Biol Reprod (Paris); 2004 Oct; 33(6 Pt 2):3S42-5. PubMed ID: 15643688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triggering ovulation with gonadotropin-releasing hormone agonists does not compromise embryo implantation rates.
    Acevedo B; Gomez-Palomares JL; Ricciarelli E; Hernández ER
    Fertil Steril; 2006 Dec; 86(6):1682-7. PubMed ID: 17074344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of GnRH antagonists and flareup GnRH agonists in donor oocyte cycles.
    Wei AY; Mijal KA; Christianson MS; Schouweiler CM; Lindheim SR
    J Reprod Med; 2008 Mar; 53(3):147-50. PubMed ID: 18441715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovarian stimulation for in vitro fertilization in patients with endometriosis.
    Zikopoulos K; Kolibianakis EM; Devroey P
    Acta Obstet Gynecol Scand; 2004 Jul; 83(7):651-5. PubMed ID: 15225190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of gonadotropin-releasing hormone agonists and antagonists on luteal function.
    DiLuigi AJ; Nulsen JC
    Curr Opin Obstet Gynecol; 2007 Jun; 19(3):258-65. PubMed ID: 17495643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal stimulation protocols for in vitro fertilization.
    Muasher SJ; Abdallah RT; Hubayter ZR
    Fertil Steril; 2006 Aug; 86(2):267-73. PubMed ID: 16753157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and endocrine response to the withdrawal of gonadotropin-releasing hormone agonists during prolonged coasting.
    Ho Yuen B; Nguyen TA; Cheung AP; Leung PC
    Fertil Steril; 2009 Aug; 92(2):499-507. PubMed ID: 18706551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of gonadotropin-releasing hormone agonist/recombinant follicle-stimulating hormone versus gonadotropin-releasing hormone antagonist/recombinant follicle-stimulating hormone on follicular fluid levels of adhesion molecules during in vitro fertilization.
    Fornaro F; Cobellis L; Mele D; Tassou A; Badolati B; Sorrentino S; De Lucia D; Colacurci N
    Fertil Steril; 2007 Jan; 87(1):39-47. PubMed ID: 17084393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving the patient's experience of IVF/ICSI: a proposal for an ovarian stimulation protocol with GnRH antagonist co-treatment.
    Devroey P; Aboulghar M; Garcia-Velasco J; Griesinger G; Humaidan P; Kolibianakis E; Ledger W; Tomás C; Fauser BC
    Hum Reprod; 2009 Apr; 24(4):764-74. PubMed ID: 19153090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initiation of GnRH antagonist on Day 1 of stimulation as compared to the long agonist protocol in PCOS patients. A randomized controlled trial: effect on hormonal levels and follicular development.
    Lainas TG; Petsas GK; Zorzovilis IZ; Iliadis GS; Lainas GT; Cazlaris HE; Kolibianakis EM
    Hum Reprod; 2007 Jun; 22(6):1540-6. PubMed ID: 17347165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of luteal estradiol patch and gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation versus microdose gonadotropin-releasing hormone agonist protocol for patients with a history of poor in vitro fertilization outcomes.
    Weitzman VN; Engmann L; DiLuigi A; Maier D; Nulsen J; Benadiva C
    Fertil Steril; 2009 Jul; 92(1):226-30. PubMed ID: 18675961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Coasting and ovarian stimulation protocols in high-responder patients undergoing assisted conception].
    Merviel P; Claeys C; Héraud MH; Lourdel E; Lanta S; Barbier F; Nasreddine A
    Gynecol Obstet Fertil; 2005 Sep; 33(9):703-12. PubMed ID: 16129645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-specific levels for basal follicle-stimulating hormone assessment of ovarian function.
    Barad DH; Weghofer A; Gleicher N
    Obstet Gynecol; 2007 Jun; 109(6):1404-10. PubMed ID: 17540814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.